Drugs / BI 1181181
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02345304 | Mar → Apr 2015 | — | Boehringer Ingelheim | Withdrawn | No outcome recorded |
| Phase 1 | NCT02254161 | Nov 2014 → Feb 2015 | — | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase 1 | NCT02106247 | Apr → Jun 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02044406 | Jan → Sep 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 1181181 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02106247 ↗ |
| Route | Oral | “single rising oral doses of BI 1181181” NCT02044406 ↗ |